HomeFilePharmacology

Pharmacology

View Category

Antiplatelet

Ticagrelor Versus Clopidogrel in Symptomatic Peripheral Vascular Disease

Peripheral vascular disease is considered as a manifestation of systemic atherosclerosis associated with adverse events, both cardiovascular...
solaci -
Learn More
Antithrombotic Anticoagulants

Anticoagulated Patients with Atrial Fibrillation Undergoing Angioplasty: How to Treat Them

In patients with atrial fibrillation undergoing coronary angioplasty with stents, standard anticoagulation with vitamin K antagonists plus...
solaci -
Learn More
Acute coronary syndromes

Ticagrelor vs. Prasugel: Similar Safety and Efficacy in Primary Angioplasty

No randomized head-to-head study comparing the efficacy and safety of ticagrelor and prasugrel has been carried out...
solaci -
Learn More
Acute coronary syndromes

Cardiovascular Events Reduction: Bivalirudin or Heparin?

The MATRIX study did not find a clear advantage of bivalirudin over unfractioned heparin to reduce major...
solaci -
Learn More
Antiplatelet

Is It Safe to Discontinue Ticagrelor One Day Before CABG?

Courtesy of Dr. Agustín Vecchia. Nearly 10% of patients with acute coronary syndrome (ACS) require surgery. Managing periprocedural...
solaci -
Learn More
Other

When to Indicate Statin Therapy

The use of non-invasive imaging can identify or rule out subclinical atheromatosis and help reduce the number...
solaci -
Learn More
Antiplatelet

Prasugrel vs. Ticagrelor in Diabetics with Heart Disease

Diabetic patients are increased risk of thrombotic events, which is why an effective antiplatelet therapy is crucial...
solaci -
Learn More
Antiplatelet

Procedural Complexity Affects Decision-Making Regarding DAPT Duration

Much of the speculation around the way of individualizing dual antiplatelet therapy (DAPT) duration after coronary angioplasty...
solaci -
Learn More